Ralph Whitworth Made Big Money on This Industrial Stock

In an amended 13G filing earlier this week, Ralph Whitworth of Relational Investors disclosed his firm had lowered its stake in Flowserve Corporation (NYSE:FLS) to 2.34 million shares, a decrease of over 30% from its 2Q stake of 3.09 million shares. Whitworth founded the firm in 1996 with the idea of investing in strategic blocks.

Ralph Whitworth

At the end of 2Q, Flowserve was Whitworth’s fifth largest position and made up 6.5% of his firm’s 13F portfolio. Not to mention, Flowserve was an entirely new position for Whitworth—so why the sudden downsize? Perhaps because the company is up 80% year to date, and up 23% since Whitworth acquired its shares in June? Whitworth and Relational Investors made over $70 million on the Flowserve trade. Unfortunately, there were not many other funds that were alongside Whitworth—see all funds owning Flowserve. However, the next largest fund owner, Breeden Capital Management, owning over 650,000 shares, had over 16% of their 13F portfolio invested in Flowserve at the end of 2Q.

Another company that Whitworth appears to be bullish on is Illinois Tool Works Inc. (NYSE:ITW). Illinois overtook Pepsi as Relational Investors’ top holding during 2Q, with the firm nearly doubling its position to 14.6 million shares and 14% of its 13F portfolio. Revenue for Illinois Tool is expected to rise only 2% in 2012 and 4% in 2013. However, global industrial and manufacturing increases will expand operating margins from 15.5% in 2011 to 16.2% in 2012—this helps put estimated 2013 EPS to $4.60, from 2012′s $4.18. Yet the company trades in line with the industry on a P/E basis, has a number of recent insider sales, and saw two of its top fund owners, Steven Cohen and Diamond Hill Capital, downsize their positions. See our other thoughts on whether Illinois Tool is a good buy.

Although it is uncertain why Whitworth may be increasing his shares of Illinois Tool, his firm did retain over 2.34 million shares of Flowserve, leading us to believe that Whitworth sees further upside potential here. A few of Flowserve’s top competitors include Sauer-Danfoss Inc. (NYSE:SHS), Xylem Inc (NYSE:XYL) and IDEX Corporation (NYSE:IEX).

Xylem is flat on the year with concerns over weakness in Europe, with reliance on demand for public utility and industrial water infrastructure products. The outlook for Xylem remains mixed, with the demand for water infrastructure projects internationally remaining weak in the interim. Unless the company can expand with acquisitions its growth remains limited.

Sauer-Danfoss trades at a discount to its peers with a P/E of 10, versus the peer average of 17x, and the company also pays the highest dividend yield at 3.3%. Sauer-Danfoss’ 2Q earnings report showed an 8% decline in sales from the same quarter last year, as well as EPS down to $1.16 from $1.54. Drought conditions and economic uncertainty will continue to put pressure on the company’s key market of engineered hydraulics.

IDEX saw 2Q orders totaling $446 million, up 4% year over year and a completion of 626,000 shares of common stock for $25.9 million. Year to date the company has returned $118 million of capital to shareholders via repurchases, dividends and debt repayment. IDEX also announced the acquisition of Matcon Ltd. in July. This will help drive next quarter EPS up by 9% from the same quarter last year and put the 5-year EPS to a 15% CAGR. The company trades at a trailing P/E of 17—in line with its peers—but trades at a forward P/E of 14.

Flowserve plans to extend its product offerings and its global reach, which should help with the expected 7% growth in sales for 2012. Key global expansion plans include strengthening operations in the Middle East, Asia and Latin America, which are Flowserve’s three weakest geographical areas. The increased demand in these areas will be spurred by a boost in oil and gas activity. Products for oil and gas make up about 40% of Flowserve’s revenues.

Even with the run up in the stock’s price, Flowserve trades at a forward P/E of 12.5 and a trailing P/E of 16, putting the company’s PEG at 1.0. With Flowserve expected to grow 2013 earnings by over 20%, it appears the company is still a good buy.

Disclosure: none

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!